Antitumor activity of the WEE1 inhibitor AZD1775 as a monotherapy and in combination with the PARP inhibitor olaparib in patient-derived explant (PDX) models

M.J. O’Connor, J.F. Liu, Sangeetha Palakurthi et al.|European Journal of Cancer|2016

Cited by 3